Core Viewpoint - The construction ceremony for the 200,000 liters/year biopharmaceutical separation and purification auxiliary materials project by Suzhou Saifen Technology Co., Ltd. was held, marking a significant milestone in the company's expansion and capacity enhancement in the biopharmaceutical sector [1]. Group 1: Project Details - The project will include the construction of three chromatography medium production workshops, along with supporting warehouses, tank areas, and wastewater treatment facilities, covering an area of approximately 21,000 square meters [1]. - The new project will add an annual production capacity of 200,000 liters of chromatography media, including affinity chromatography fillers, ion exchange fillers, and composite chromatography fillers [1]. Group 2: Company Performance - Saifen Technology has been actively involved in the rapid development of China's biopharmaceutical industry, accumulating over 100 application projects in various biopharmaceutical segments, including antibodies and insulin [2]. - The company reported a strong business performance since its listing on the STAR Market, achieving a revenue of 302 million yuan in the first three quarters of 2025, a year-on-year increase of 38.39%, and a net profit of 93.21 million yuan, up 71.07% [3]. Group 3: Market Context - The rapid development of the Chinese biopharmaceutical industry is highlighted by significant achievements from partners of Saifen Technology, indicating a growing demand for high-performance, large-scale, and high-quality domestic chromatography fillers [4]. - The new project will enhance the company's ability to deliver on a large scale and support the stable production and capacity growth of its partners, while also aiding in the company's strategy to expand into overseas markets [4].
赛分科技扬州二期项目开工 新增年产能20万升